Concepedia

Satoru Motoyama

SM

Statistics

Publications

148

Citations

6.3K

H-Index

37

Active since

1986

Affiliations

Akita University(Current)

Akita University Hospital

Kobe University

Bristol-Myers Squibb (United States)

Satoru Motoyama is an author at Akita University specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1986–2025

148

Publications

148

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki, Jaffer A. Ajani, Ken Kato et al. · UCL Discovery (University College London) · 2022 · 532 citations · Full text

Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung

Yoshihiro Minamiya, Takashi Ono, Hajime Saito et al. · Lung Cancer · 2011 · 141 citations

, , +10

Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.

Ian Chau, Yuichiro� Doki, Jaffer A. Ajani et al. · Journal of Clinical Oncology · 2021 · 110 citations

The role of human papilloma virus in the molecular biology of cervical carcinogenesis.

Satoru Motoyama, Cecilia A. Ladines‐Llave, Salvador Luis Villanueva et al. · PubMed · 2004 · 103 citations

, , +23

Rows per page

1–5 of 148